Trauma severity-dependent changes in at III activity

Shock

Volumn 15, Issue 5, 2001, Pages 344-347

  Liener, Ulrich Christoph ^a   Brückner, Uwe Bernd ^a   Strecker, Wolf ^b   Steinbach, Gerald ^a   Kinzl, Lothar ^a   Gebhard, Florian ^a  

^a UNIVERSITY OF ULM   (Germany)

^b NONE

Author keywords

Coagulation; Humans; Injury; Interleukin (IL) 6; On the scene investigation; Prospective clinical study

Indexed keywords

ANTITHROMBIN III; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; INJURY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; WOUNDS AND INJURIES;

EID: 0039189867     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115050-00002     Document Type: Article

References (20)

1. Rosenberg RD, Damus PS: The purification and mechanism of antithrombin-heparin cofactor. J Biol Chem 248:6490-6505, 1973.
2. Engelmann DT, Gabram SGA, Allen L, Gordon EE, Jacobs LM: Hypercoagulability following multiple trauma. World J Surg 20:5-10, 1996.
3. Fourrier F, Chopin C, Huart JJ, Rungel, Caron C, Goudemand J: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104:882-888, 1993.
4. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Brückner UB: Interleukin-6, an early marker of injury severity following trauma in humans? Arch Surg 135:291-295, 2000.
5. Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K: Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 93:157-164, 1999.
6. Horie S, Ishii H, Kazama M: Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res 59:895-904, 1990.
7. Inthorn D, Hoffmann JN, Hartl WH, Mühlbayer D, Jochum M: Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock 10:90-96, 1998.
8. Jochum M: Influence of high dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines and soluble adhesion molecules in acute inflammation. Semin Hematol 32:19-32, 1995.
9. Miller RS, Weatherford DA, Stein D, Crane MM, Stein M: Antithrombin III and trauma patients: factors that determine low levels. J Trauma 37:442-445, 1994.
10. Nast-Kolb D, Waydhas C, Gippner-Steppert C, Schneider I, Trupka A, Ruchholtz S, Zettl R, Schweiberer L, Jochum M: Indicators of the post-traumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma 42:446-455, 1997.
11. Niessen RWLM, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB, de Vijlder JJM, ten Cate JW, Hack CE, Sturk A: Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb Haemost 78:1088-1092, 1997.
12. Okjiama K, Uchiba M: The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost 24:27-32, 1998.
13. Owings JT, Bagely M, Gosselin R, Romac D, Disbow E: Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma 41:396-406, 1996.
14. Penner J: Antithrombin deficiency in special clinical syndromes, part II: trauma/ burns. Semin Hematol 32:42-47, 1995.
15. Diaz-Cremades JM, Lorenzo R, Sanchez M, Alsar MJ, Bosch JM, Fajardo L, Gonzalez D, Guerrero D: Use of antithrombin III in critical patients. Intensive Care Med 20:577-580, 1994.
16. Schipper HG, Roos J, van de Meulen F, ten Cate JW: Antithrombin III deficiency in surgical intensive care patients. Thromb Res 21:73-80, 1981.
17. Vinazzer HA: Antithrombin III in shock and disseminated intravascular coagulation Clin Appl Thromb Hemost 1:62-65, 1995.
18. Waydhas C, Nast-Kolb D, Gippner-Steppert C, Trupka A, Pfudstein C, Schweiberer L, Jochum M: High-dose antithrombin III treatment of severely injured patients: results of a prospective study. J Trauma 45:931-940, 1998.
19. Waydhas C, Nast-Kolb D, Kick M, Trupka A, Zettl R, Wiesholler H, Schmidbauer S, Jochum M, Schweiberer L: Disturbance of homeostasis after trauma surgery of varying severity. Unfallchirurg 98:455-463, 1995.
20. Wilson RF, Mammen EF, Tyburski JG, Warsow KM, Kubinec SM: Antithrombin levels related to infections and outcome. J Trauma 40:384-387, 1996.